As of April 18, 2025, Gamida Cell (GMDA) has a market cap of $4.337 million USD. According to our data, Gamida Cell is ranked No.9036 in global market value.
Year | Market Cap | %Change |
---|---|---|
May 24, 2024 | $4.34 M |
-95.88%
|
Dec 29, 2023 | $54.74 M |
-68.01%
|
Dec 30, 2022 | $0.17 B |
-49.21%
|
Dec 31, 2021 | $0.34 B |
-69.73%
|
Dec 31, 2020 | $1.11 B |
95.12%
|
Dec 31, 2019 | $0.57 B |
-56.74%
|
Dec 31, 2018 | $1.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.20 B |
49.857 M
|
![]() France
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
Market Cap | = | GMDA Stock Price | * | GMDA Shares Outstanding |
= | $0.03 | * | 0.13 B | |
= | $4.34 M |